The regulatory state, some writers claim, arose in response to failures of the legal system. In the case of blood markets, however, regulation came about not from public outcry caused by faulty laws and courts, but from lobbying by interest groups who expected special benefits from regulation.
Michael D. Thomas is Assistant Professor of Economics at Creighton University.
Diana W. Thomas is a Senior Fellow at the Independent Institute, Associate Professor of Economics and Director of the Institute for Economic Inquiry in the Heider College of Business at Creighton University, and Co-Editor of The Independent Review: A Journal of Political Economy.
EconomyFDA and Drug RegulationFree Market EconomicsHealth and Healthcare
Other Independent Review articles by Michael D. Thomas
Winter 2023/24 Living Better Together: Social Relations and Economic Governance in the Work of Ostrom and Zelizer
Fall 2020 Markets against Modernity: Ecological Irrationality, Public, and Private
Spring 2018 Inside Job: How Government Insiders Subvert the Public Interest
[View All (4)]
Other Independent Review articles by Diana W. Thomas
Fall 2024 Hannah’s Children: The Women Quietly Defying the Birth Dearth
Spring 2024 The Power of Hope: How the Science of Well-Being Can Save Us from Despair
Spring 2024 The Human Prosperity Project: Essays on Socialism and Free Market Capitalism from the Hoover Institution
[View All (6)]